Midodrine hydrochloride in patients on hemodialysis with chronic hypotension

Renal Failure

Volumn 18, Issue 2, 1996, Pages 253-260

  Fang, Ji Tseng ^a   Huang, Chiu Ching ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chronic hypotension; Hemodialysis; Midodrine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; MIDODRINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FLUSHING; HEADACHE AND FACIAL PAIN; HEMODIALYSIS; HUMAN; HYPOTENSION; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UREMIA; VASCULAR RESISTANCE; VERTIGO; VISUAL IMPAIRMENT;

EID: 0029872049     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052795     Document Type: Article

References (30)

1. Sorensen SS, Danielsen H, Jespersen B, Pedersen B: Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Clin Nephrol 26:288-296, 1986.
2. Bradley JR, Evans DB, Cowley AJ: Comparison of vascular tone during combined haemodialysis with ultrafiltration and during ultrafiltration followed by haemodialysis: a possible mechanism for dialysis hypotension. Br Med J 300:1312-1313, 1990.
3. Sturani A, Esposti ED, Chiarini C, Spongano M, Santoro A, Zucchelli P: Failure of naloxone in reversal hemodialysis-induced hypotension. Blood Purif 3:184-186, 1985.
4. Campese VM: Orthostatic hypotension: idiopathic and uremia. Kidney Int 25(suppl):152-155, 1988.
5. Lamas S, Quereda C, Orofino L, Marcen R, Garcia F, Ortuno J: Autonomic neuropathy and symptomatic hypotension in hemodialysis patients. Nephron 46:107-108, 1987.
6. Malik S, Winney RJ, Ewing DJ: Chronic renal failure and cardiovascular autonomic function. Nephron 43:191-195, 1986.
7. Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q: Parasympathetic function in haemodialysis patients. Nephron 44:351-354, 1986.
8. Solders G, Persson A, Gutierrez A: Autonomic dysfunction in non-diabetic terminal uremia. Acta Neurol Scand 71:321-327, 1985.
9. Zucchelli P, Sturani A, Zuccala A, Santoro A, Esposti ED, Chiarini C: Dysfunction of the autonomic nervous system in patients with end-stage renal failure. Contr Nephrol 45:69-81, 1985.
10. Chu TS, Tsai TJ, Lee SH, Yen TS: Evaluation of cardiovascular autonomic function tests in dialysis patients. J Formos Med Assoc 92:237-240, 1993.
11. Yamazaki R, Tsuchida K, Alhara H: Effects if alpha-adrenoreceptor agonists on cardiac output and blood pressure in spinally anesthetized ganglion-blocked dogs. Arch Int Pharmacodyn Ther 295:80-93, 1988.
12. Jankovic J, Gilden JL, Hiner BC, Brown DC, Rubin M: Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 95:38-48, 1993.
13. Schirger A, Sheps SG, Thomas JE, Fealey RD: Midodrine: a new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome. Mayo Clin Proc 56:429-433, 1981.
14. Zachariah PK, Bloedow DC, Moyer TP, Moyer TP, Sheps SG, Schirger A, Flealey RD: Pharmacodynamics of midodrine, an antihypotension agent. Clin Pharmacol Ther 39:586-591, 1986.
15. McTavish D, Goa KL: Midodrine: a review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 38:757-777, 1989.
16. Kaufman H, Brannan T, Krakoff L, Yahr MD, Mandeli J: Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 38:951-956, 1988.
17. Moore TJ, Lazarus ML, Hakim RM: Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients. Kidney Int 36:696-701, 1989.
18. Iseki K, Massry SG, Campese VM: Evidence for a role of PTH in the reduced pressor response to norepinephrine in chronic renal failure. Kidney Int 28:11-15, 1985.
19. Onoyama K, Hori K, Osato S, Fujishima M: Haemodynamic effect of recombinant human erythropoietin on hypotensive haemodialysis patients. Nephrol Dial Transplant 6:562-565, 1991.
20. Heintz B, Reiners K, Gladziwa U, Kirsten R, Nelson K, Wieland D, Riehl J, Mann H, Sieberth: Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients. Clin Nephrol 39:198-204, 1993.
21. Daul AE, Wang XL, Michel MC, Brodde OE: Arterial hypotension in chronic hemodialyzed patients. Kidney Int 32:728-735, 1987.
22. Ellis AN, Vaziri ND, Maksy M: Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease. Arch Intern Med 145:1013-1015, 1985.
23. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG: Mechanism of autonomic nervous system dysfunction in uremia. Kidney Int 20:246-253, 1981.
24. Collins J, Massry SG, Campese VM: Parathyroid hormone and the altered vascular response to norepinephrine in uremia. Am J Nephrol 5:110-113, 1985.
25. Taneva OS, Masin G, Poenakovic M, Stojcev S, Stojkovski L: Autonomic nervous dysfunction and volume nonresponsive hypotension in hemodialysis patients. Am J Nephrol 11:123-126, 1991.
26. Hines S, Houston M, Robertson D: The clinical spectrum of autonomic dysfunction. Am J Med 70:1091-1096, 1981.
27. Schatz IJ: Orthostatic hypotension: II. clinical diagnosis, testing, and treatment. Arch Intern Med 144:1037-1041, 1984.
28. Puchmayer V, Herdova J, Krejcova H, Masopust J: Midodrine, a new therapeutic agent: recent experience. Int Angiol 12:113-118, 1993.
29. Petelez T, Sosnowski M, Axenti I: Gutron treatment of patients suffering from essential orthostatic hypotony. Int Angiol 12:138-144, 1993.
30. Yang TM, Chiang BN, Chang MS: Treatment of postural hypotension with a peripheral alpha-adrenergic agonist (midodrine) in the elderly. Acta Cardiol Sin 6:119-130, 1990.